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Summary 
To investigate the structural and genetic basis of the T cell response to defined peptide/major 
histocompatibility (MHC) class II complexes in humans, we established a large panel of T cell 
clones (61) from donors of different HLA-DR haplotypes and reactive with a tetanus toxin-derived 
peptide (tt830-844) recognized in association with most DR molecules (universal peptide). By 
using a bacterial enterotoxin-based proliferation assay and cDNA sequencing, we found preferential 
use of a particular VB region gene segment, VB2.1, in three of the individuals studied (64%, 
n =  58), irrespective of whether the peptide was presented by the DR6wcI, DR4w4, or DRw11.1 
and DRw11.2 alleles, demonstrating that shared MHC class II antigens are not required for shared 
V/~ gene use by T  cell receptors (TCRs)  specific for this peptide. Vot gene use was more 
heterogeneous, with at least seven different Vc~ segments derived from five distinct families encoding 
ot chains able to pair with V132.1 chains to form a tt830-844/DR-specific binding site. Several 
cases were found of dories restricted to different DR alleles that expressed identical VI3 and (or 
very closely related) Vo~ gene segments and that differed only in their junctional sequences. Thus, 
changes in the putative complementary  determining region 3 (CDR3) of the TCR may, in certain 
cases, alter MHC specificity and maintain peptide reactivity.  Finally, in contrast to what has 
been observed in other defined peptide/MHC systems, a striking heterogeneity was found in 
the junctional regions of both c~ and 13 chains,  even for TCRs with identical Vol and/or VI3 
gene segments and the same restriction. Among 14 anti-tt830-844 clones using the V/32.1 gene 
segment, 14 unique VI3-D-JI3 junctions were found, with no evident conservation in length 
and/or amino acid composition. One interpretation for this apparent lack of coselection of specific 
junctional sequences in the context of a common V element, VB2.1, is that this V region plays 
a dominant role in the recognition of the tt830-844/DR  complex. 
l~ 
cognition by T cells of antigens presented in the form 
of short peptide fragments bound to self-MHC mole- 
cules is mediated through a clonotypic cell surface hetero- 
dimer receptor (TCR) composed of an o~ and 13 chain (1, 2). 
The TCR specificity resides in the amino terminal ot and 13 
variable domains which are generated as a result of combina- 
torial juxtaposition of germline-encoded V, D (for the 13 chain), 
and J gene segments and by somatic diversification  mecha- 
nisms  operating  at  the  Vol-Jcx and  VIJ-D-JB  junctions 
(reviewed in reference 3). 
Amino acid sequence comparison of the cr and 13 V regions 
with their Ig counterparts have shown a remarkable conser- 
vation of residues critical for maintaining the basic architec- 
ture of the Ig V regions (4, 5). Thus, although the three- 
dimensional structure of the TCR is not yet known, it has 
been predicted that its V regions fold and pair similarly to 
Ig V regions (3-5). Furthermore, the identification of hyper- 
variable regions in both c~ and/3 subunits (more evident, how- 
ever, for the 13 chain)  at sites corresponding approximately 
to the Ig CDRs 1, 2, and 3 (6-8), suggests that in the TCR 
these regions contribute to the interaction with the peptide 
antigen/MHC complex. However, in contrast to Igs, somatic 
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appear to play a significant role in the generation of diversity 
(9),  implying, perhaps,  that preservation of the germline- 
encoded CDKs is an important factor in maintaining TCR 
specificity. 
Structural  analysis  of T  cell  responses  to  defined pep- 
tide/MHC class II complexes in the.mouse has indicated that 
TCKs with the same specificity tend to use a limited set of 
V gene segments (10o18), and that the use of particular Vot 
(10, 11, 13) or V/3 (10-12) segments correlates with antigen 
or MHC recognition. Moreover,  TCRs using the same V 
gene segments often have been found to express very similar 
junctional sequences in both length and amino acid compo- 
sition (14-18),  arguing in favor of a key role of these junc- 
tional regions in the recognition of a given antigen/MHC 
class II complex. 
In the present study we sought to obtain further insights 
into the molecular mechanism of antigen and MHC recog- 
nition. As a model system we chose to analyze the V region 
structural components of HLA-DR-restricted TCRs selected 
in response to an epitope defined by a short synthetic peptide 
comprising  residues  8300844  of tetanus  toxin  (tt) 1 (19). 
Previous  investigations have established  that this peptide is 
universally immunogenic, since it is recognized in all tetanus 
toxoid (TT)-primed donors tested irrespective  of their DR 
haplotype (20),  and that it appears to bind to different DR 
molecules in a similar orientation as demonstrated by experi- 
ments using truncated and substituted peptide (20, 21); and 
by the fact that some (promiscuous) clones recognize the pep- 
tide bound to several (up to five) different MHC alleles (21, 
22). This system therefore allows one to evaluate the impact 
of  restricting element polymorphism on the structure of  TCRs 
specific for the same immunogenic peptide. This polymor- 
phism may determine both the way in which a peptide binds 
to a particular MHC molecule and its interaction with the 
TCR (23). 
We established a large panel of anti-tt830-844 T cell clones 
restricted to the same or different DR alleles from several 
TT-primed donors with distinct HLA-DR haplotypes and 
asked whether and at which level structural constraints are 
imposed on the corresponding TCKs. Our results indicate 
that a particular VB region, encoded by the V~2.1 gene seg- 
ment, is strongly selected in different individuals in the anti- 
tt830-844  response regardless  of the DR allele (DRw6cI, 
DR4w4, DRw11.1, and DKw11.2) presenting the antigen. 
This suggests that this VB region may interact with a common 
structural element of these complexes. We then analyzed the 
Vc~ segments expressed by 14 V~2.1-positive clones,  most 
of them restricted to the DKw6cI allele, and found that at 
least seven different ones could be used to form anti-tt8300844 
specificities. It is surprising to note that, in contrast to the 
apparent coselection of similar junctional sequences  in the 
context of common V  elements reported in other model 
1Abbreviations used in  this paper: A-PCR, anchored polymerase chain 
reaction; MBP, myelin  basic protein; TSST-1, Staphylococcus  toxic shock 
syndrome toxin 1; tt, tetanus toxin; TT, tetanus toxoid. 
systems, the junctional regions of both the ot and ~  chains 
of these TCRs were extremdy diversified,  even for TCRs 
using the same Vot and VB gene segments and restricted to 
the same DR molecule. These data indicate a limited conser- 
vation of TCR V  region components selected in response 
to the antigen/MHC complexes  studied, and are discussed 
in the context of possible models of TCR/Ag/MHC recog- 
nition. 
Materials and Methods 
Isohtion of l~pti&-specific T Cell Clones.  The tt830-844-specific 
T cell clones were isolated from PBMC of HLA-typed TT-primed 
donors, and characterized  as previously  described (20). The isotype 
of class II molecules recognized by each T cell clone was deter- 
mined by antibody blocking experiments, and the DK restricting 
alleles were identified by using a panel of HLA-DR homozygous 
EBV B cells as APC (20). 
Antigens.  Peptide tt830-844,  corresponding to amino acids 
830-844 of tt (QYIKANSKFIGITEL), was mapped and synthe- 
sized as described (19). Native tt was obtained from Calbiochem 
Corp. (La Jolla, CA). TT was obtained from the Swiss Serum In- 
stitute (Bern, Switzerland).  Purified  Staphylococcus  toxic shock system 
toxin  1)  (TSST-1) was purchased from Toxin Technology Inc., 
(Madison, WI), 
T celIProlif~tion  Assays.  Cultures were set up in 200 #1 RPMI- 
FCS in flat-bottomed microphtes. T cells 0  x  104) were cultured 
with 2  x  104 irradiated (6,000 tad) EBV-transformed  B cells. TT 
(1-100 #g/ml), peptide tt830-844  (0.01-20 #g/ml), or TSST-1 
(0.1-50 ng/ml) were either added in the culture or used to pulse 
the EBV B cells. After 2 d at 37~  5% CO2, the cultures were 
pulsed  with  1  #Ci  [~H]thymidine (Amersham International, 
Amersham, Bucks, UK) (sp act, 5 Ci/mmol), and incorporated 
radioactivity was measured after an additional 16 h by liquid scin- 
tillation. 
PCR A raplification and Sequence Analysis of TCR-ct and-B eDNA. 
Total KNA was prepared from  5-10  x  106  ceils by the  acid 
guanidininm  thiocyanate-phenol-chloroform extraction  method 
(24). Yields were usually 5-10 #g of total RNA for 106 cells. A 
previously described anchored-PCR (A-PCK) technique (25) was 
used with slight modifications.  Single-strand eDNA was obtained 
using reagents from a eDNA synthesis kit (Boehringer Mannheim 
Corp., Indianapolis, IN).  5 #g of total RNA was used for each 
synthesis that was performed in 20 #1 for 1.5 h at 42~  according 
to the manufacturer's instructions. The reaction mixture was then 
precipitated by isopropanol in I M ammonium acetate to eliminate 
free nucleotides  and the oligo(dT) primer. A poly(dG) tail sequence 
was then added to the sscDNA with terminal deoxynucleotidyl 
transferase (IBI, New Haven, CT) in a 40-#1reaction mixture con- 
taining a cobalt TdT buffer (IBI), and 0.1 mM dGTP for 30 min 
at 37~ 
Amplification of ~ and B variable regions were performed with 
Thermus aquaticus ~aq) polymerase  (Perkin  Elmer Cetus Corp., Nor- 
walk, CT) by using 10% of the G-tailed sscDNA in the standard 
buffer containing 50 pmol of each of two oligo-primers in a final 
volume of 100 #1. One of the two primers contained a sequence 
(underlined) complementary to the poly(G) (5'-CACTCGAGC- 
GGCCGCGTCGACCCCCCCCCC-Y),  and the other contained 
a sequence  complementary  to either the 5' end of,', constant region 
(  5'-GCGAATTCAGATCTTAGCK;AGACAGACTTGTCA~  - 
3'), or the 5' end of/~ comtant region (5'-GC'IUTAGAG'~GACGC~ 
CTGCTCAGGCAGTA_TCTGGAGT-Y).  The latter primer and a 
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AGGCGTCGAGAAGG-Y) were used to detect expression of V/82 
in GC clones. Amplification primers contained,  in addition,  re- 
striction  sites used for cloning.  Each reaction  mixture was sub- 
jeered to  a denaturation  step  at  940C  for  5 min,  then  to  25 
amplification cycles  in a thermocycler (Hybaid, Teddington, Middle- 
sex, UK), each consisting of a 10-s denaturation  step at 940C, a 
1-min annealing step at 550C, a 15-s primer stabilization at 60~ 
and a 45-s elongation step at 720C. A final extension step at 72~ 
for 5 min terminated  the reaction. 
PCK products were digested  with Sail and BgllI restriction 
enzymes. The Sail site was located in the anchor-oligo-primer  and 
BgllI site in the ot constant  specific primer  or in the/8 constant 
region.  Amplified products (of ,o600-700 bp) containing  c~ or/8 
variable regions  were agarose gel purified,  subcloned  into  the 
M13mp19 bacteriophage  vector, and sequenced according to the 
dideoxynucleotide  termination  method (26). Sequencing primers 
were either  the universal MD forward primer (U.S. Biochemical 
Corp., Cleveland, OH) or ~  or fl specific primers:  5'-GCGAA- 
T TCAGATCTTAGGCAGACAGACTTGTC ACTGC~Y, comple- 
mentary to the c~ constant  region;  5'-TCTGCTTCTGATGGCT- 
CAAAC-Y,  complementary  to the/8 constant  region;  51CCG  - 
GGGTATIGCACATACCA-Y, 5tCCAGGATCCTG~CCA-Y, 
and 5'-CAAGGGTCCTGCCGAAACCA-Y,  degenerated primers 
complementary  to a consensus sequence located in the ct variable 
region and 5'-CCCAGGGTCTGTCGGTACCA-3',  a degenerated 
primer complementary  to a consensus sequence in the/8 variable 
region. Several independent MD subclones (usually 5-10) were se- 
quenced because PCR amplification is known to introduce errors 
through base misincorporation  (27), and because the ~ (and pos- 
sibly the B) loci of both chromosomes may undergo functional rear- 
rangements  (28, 29). Sequence homology comparisons with se- 
quences obtained from GenBank were performed by using the Fastp 
program (30), and MV10000 computer facilities (Centre de calcul, 
Pasteur Institute,  Paris, France). 
Northern Blot Analysis of V/82 Expression.  For each clone, 2.5 
/~g of total RNA was denatured at 65~  in formamide buffer, and 
electrophoresed on 1.3% agarose gels containing  1.7% formalde- 
hyde. RNAs were then transferred to nylon membranes (Hybond, 
Amersham,  UK), using a Fast trans apparatus (Genofit, Geneva, 
Switzerland),  and filters baked for 2 h at 80~  Filters were pre- 
hybridized for 2.5 h at 650C in Church's buffer (0.5 M phosphate 
buffer, pH 7.2, 7% SDS). Hybridization  was performed  for 4 h 
at  65~  in  the  same  buffer  containing  2  ￿  l&  cpm/ml  of 
[32p]random-priming-labeled (31) V/82.1 eDNA probe. The probe 
was derived from a human T cell clone (GM2.11) (20) that was 
found to express Vfl2.1 as detected by nucleotide sequencing (data 
not shown), and by specific PCR amplification as described above. 
The amplified DNA was digested with PatI restriction enzyme to 
remove the junctional region and V/8 fragment purified on an agarose 
gel. Hybridized filters were washed twice in 2x  SSC, 0.1% SDS, 
then once in lx  SSC, 0.1%  SDS at 65"C. Membranes were ex- 
posed overnight to Kodak X-OMAT AR film using an intensifying 
screen. 
HLA-DR Typing.  The DR phenotyping of donors GC, KK, 
GAK, and BDM was assigned by serological typing (20). The DR 
phenotype of GC was also determined by PCK and hybridization 
with a DRw11.l-specific oligonucleotide (Dr. G. Mazzola, Torino, 
Italy, personal communication).  To obtain  the precise HLA-DR 
allele expressed by donors AL (previously reported to be homozy- 
gous DRw13 [w6] by serological typing [20]) and donor BK, typing 
was performed by PCR amplification and sequencing of the first 
domain of the HLA-DR/8 chain using eDNA prepared as described 
above. Amplification  primers  were 5'-GTTCTAGAGTCGACG- 
GC~ACACCGGACCACGTTCC-Y  and  5'-CACGAATTCGG- 
ATCCTCGCCGCTGCACTGTGAAGC-Y, complementary to the 
5' and 3' regions of the first domain of the HLA-DR B chain, respec- 
tively, (32) which allowed amplification of HLA-DR /81, /83, and 
/84 isotypes. Thus, to obtain at least a few representative sequences 
for each allele, 10 and 20 independent sequences were determined 
from donors  AL and BK, respectively. 
Results 
Preferential Use of  a Vff2 Famil  7 Member among DR-restricted 
T CellClones Specific  for tt830-844.  61 anti-tt830-844 DK- 
restricted  T  cell clones were isolated from  six TT-primed 
donors expressing the same or different DR alleles (Table 1). 
Some of these clones express a promiscuous pattern of recog- 
nition (20), since they are capable of effaciently recognizing 
tt830--844 presented by the autologous DR,  as well as by 
other DRs.  Thus,  for example,  certain clones from donor 
AL (homozygous DKw6cI) react with peptide presented by 
the DKwll.2 molecule in addition to the autologous DK. 
When cDNAs corresponding  to the TCK 13 chains of a 
number of clones from donors AL and BK were isolated by 
the A-PCR technique (25) and sequenced, it was found that 
the majority used a V~2 gene family member, V/32.1. In both 
donors we found two V/32.1  sequences, one that  matched 
a previously published sequence (33), referred to as V/32.1a 
(34), and the other that differed by a single nudeotide sub- 
stitution resulting in an Arg instead of a Trp at amino acid 
position 10 (numbering according to Kabat et al.  [35], not 
shown). This latter sequence is likely to represent an alldic 
variant of V/32.1 that has been named V/32.1c, to distinguish 
it from a third allde, V/32.1b,  that differs from V/32.1c by 
a single amino  acid (Lys  42 substituted by Gin)  (34). 
T  ceUs expressing Vf32 have been reported to proliferate 
in response to TSST-1 superantigen bound to class II MHC 
molecules (36).  To determine whether this property could 
be used to rapidly and reliably check for V/32 expression, 16 
AL clones were tested both for their  ability to respond to 
TSST-1 presented by autologous EBV-transformed B cell lines, 
and for V/32.1 expression by Northern blot hybridization anal- 
ysis.  The results presented in Fig.  1 demonstrate  a perfect 
correlation between a proliferative response to TSST-1  and 
expression of V/32.1. These data also indicate that the substi- 
tution at amino acid position 10 that accounts for the two 
V/32.1  alleles  does not affect the interaction  with  TSST-1. 
Altogether,  13 of 21 clones (,v60%) from AL and four of 
eight (50%) from BK all restricted to DKw6cl, proliferated 
in response to TSST-1 (Table 1).  In addition,  four of eight 
clones (50%) from donor BR that recognized tt830-844 in 
the context of DK4w4 were positive in the TSST-1 stimula- 
tion  assay  (Table  1). 
Sequencing  of TCK-/3 cDNAs of 15 TSST-l-responsive 
clones from donors AL and BR indicated that, as expected, 
all expressed V/32.1 (Table 2). In contrast,  14 unique V/3-D- 
J/3 junctional sequences were found (Fig.  2). Clones AL8.1 
and ALl2.1, which used the same Vot and V/3 gene segments 
and had identical ot and/3junctional sequences, were derived 
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Donor  HLA-DR* restriction  Frequency of 
(HLA-DR haplotype)*  of T cell clones  VB2.1 + T cell clones*  Total 
AL  DRw6cI,  DKw11.2  7/8 
(DRw6cI, DRw6cI)  DRw6cI  6/13 
BK  DRw6cI,  DRw11.1,  DRw11.2  2/2 
(DRw6cI, DK4w4)  DRw6cI, DRw11.1  1/1 
DRw6cI, DRw11.2  0/1 
DRw6cI  1/4 
DR4w4  4/8 
13/21 
8/16 
GC 
(DRw11.1,  DRw11.1)  DRw11.1  16/21 
KK 
(DR11.1,  DR3)  DR11.1  0/1 
GAR 
(DRw11.1,  DR1)  DRw11.1  0/1 
BDM 
(DR11.1,  DRw11.1)  DRw11.1  0/1 
Most of the clones proliferated in response to low concentration of peptide (0.02-1 #g/ml) as well as to the native tt molecule presented by autologous 
APC, demonstrating  that these clones are indeed tetanus specific. 
* The nomenclature of each DR allele is according to reference 32. 
*  VB2 expression was assessed  by TSST-1 proliferation assay (described in Materials and Methods) for all the clones indicated except for three clones 
from donor GC where VB2.1 expression was determined by PCR using VB2.1- and C/~-specific  primers (data not shown). 
from two independent in vitro primary cultures,  strongly 
suggesting that the same clone present in PBMC had been 
independently  isolated twice. Thus, 14 anti-t*830-844 clones 
from two donors,  each expressing an independent ~  rear- 
ranging event, used V32.1. 
To determine whether other VB germline gene segments 
were preferentially used in the anti-*t830-844  response, a 
sample of eight TSST-l-unresponsive clones (three each from 
donors AL and BR, and one each from donors KK and GAK; 
Table 1) was subjected  to sequence  analysis. As expected, V32.1 
was not expressed in any of these clones (Table 2). Further- 
more, in contrast to the repeated usage ofV32.1, no selected 
use of other V3 gene segments emerged since the AL clones 
expressed V~21.3, V~6.9, and V~19.1, the BR clones V/38.3, 
V313.6 (a new member of  this gene family; Fig. 3), and V37.2, 
and the KK and GAR clones V/~12.3 and V319.1,  respec- 
tively. No significantly greater degree of amino acid sequence 
identity could be demonstrated between VB2.1 and any of 
these  gene segments  ('~30%),  than between V32.1  and 
members of other V3 families. 
As V32.1 was found to be used by TCRs restricted to two 
distinct DR alleles (DRw6cI and DR4w4), we tested whether 
anti-tt830-844  clones  isolated  from  a  third  donor,  GC 
(homozygous D Rw11.1), also preferentially used V32.1. This 
haplotype was particularly  interesting as 10 of 17 VB2.1- 
positive, DRw6cI-restricted clones from individuals AL and 
BR were promiscuous for DRw11.1 and/or DRw11.2 (Tables 
1 and 2). It was found that 16 of 21 clones (76%) from donor 
GC expressed V~2.1, as indicated by proliferation to TSST-1 
and/or PCR (Table 1). 
In conclusion,  the above results indicate that, at least in 
certain individuals, V~2.1  is strongly selected for recogni- 
tion of tt830-844 whether presented by any of three different 
DR alleles, and suggest that this V segment may be inter- 
acting with a structural determinant common to these DR 
complexes. 
Anti-tt830-844 Clones Display a Profile of Vol Gene Use that 
May  Be  Particular to  Each Donor.  We  then  investigated 
whether, as observed for V~ particular Vot family members 
were also selected in response to tt830-844 by determining 
the nudeotide sequences of the Vot segments expressed in 
clones whose V~s had been characterized (Table 2). Two dis- 
tinct ~ sequences  were often found in a given clone, although 
in two-thirds of the cases one of the two was the result of 
a nonproductive rearrangement (i.e., VoeJol  junction not in 
frame, indicated by * in Table 2). In clones AL4.1, ALIII6.3, 
BR7.5, and GAR9.2, two functional ol chains were detected. 
In each of these clones, sequencing of 8-10 independent ~/ 
cDNAs did not reveal  the presence of a second V~ suggesting 
that the expression of two cr  chains is likely to be due to 
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in AL clones and their proliferative response to the TSST-1. 
Total RNA ("o2.5  ~g), isolated from the indicated  clones, 
was  stained with ethidium bromide to assess the integrity 
of the 28S and 18S rRNA (top),  and subjected to Northern 
blot analysis (bottom).  Hybridization was performed with a 
V/32.1 probe isolated from done GM2.11 (20) (see Materials 
and Methods).  RNA from GM2.11 was used as a positive 
control. The negative  control was RNA isolated  from the 
J77 Jurkat cell line, which expresses a V~58 gene (37). The 
positions  of 28S and 18S rRNA are indicated on the autora- 
diograrn  (lower).  Hybridization with the V132.1 probe gives 
a band  of the expected size ("~1.3 kb) for TCR-B mRNA. 
Under each lane is indicated whether the clone responded (+) 
or not ( - ) to TSST-1  at concentratiom of  0.1-50 ng/ml. Clones 
were considered positive when the level of [3H]thymidine in- 
corporation was above 104 cpm over a background of 103 
cpm. Most of the clones responding  to TSST-1 gave a max- 
imal incorporation between  5  x  104 and  2  x  10  s cpm. 
Clones nonresponding  to TSST-1 gave values equal to nega- 
tive control (without TSST-1). In none of the reported ex- 
periments  was the background above 103 cpm. 
lack of allelic exclusion at the level of a  rearrangement (28), 
rather than to contamination by a second T  cell done. In 
the remaining clones, a single Va could be detected in 5-10 
independent cDNAs sequenced. It is of  interest that, besides 
the unique human Ca sequence described (43), we found 
a variant in individual AL in which Ash at position 120 of 
the C region is replaced by Lys (Hg. 2) as the result of  a single 
nucleotide substitution.  This could correspond to an allelic 
variant of Cc~, because in the AL donor, both forms were 
found in different clones and, when two a  sequences (out 
of frame, not shown, or in frame, Fig. 2) were present  in 
a given done, each of  them expressed one of these two forms. 
This further reinforces the notion of lack of allelic exclusion 
for ol chain rearrangement. 
As shown in Table 2, clones from donor AL preferentially 
used the Va21.1 and Va17.1 family members, each in at least 
3 and potentially 4 of 10 clones, whereas in the BK donor, 
two members of the Va2 family, Va2.2,  and 2.6,  are ex- 
pressed in 4 (or 5) of 10 clones. Thus, individuals AL and 
BK display similar high frequencies of V132.1 use (~>50%), 
and their profile of  Va use is more heterogeneous  and shows 
considerably less overlap. Some shared use of Va gene seg- 
ments, however, does occur, in that Vc~l family members 
are expressed in clones AL9.2, BK7.3, and BK22.5, and Va8 
family members are found in clones AL8.1, BR1.7,  BR7.5, 
and GAR9.2. Nevertheless, certain gene segments appear to 
be preferentially used in each individual.  A new Vc~ family 
(Va30), a new member of the Va14 family (Va14.1),  and 
a new Jol gene segment (AL 6.3) were identified (Fig. 3). 
Multiple Combinations of Va and V[3 Gene Segments Are 
Found to Constitute TCRs Specific  for tt830-844.  As shown 
in Table 2, a rather diversified  repertoire ofVc~ germline gene 
segments  coexpressed with Vf52.1 was  evident,  although 
repeated  use of  the same or a related  Va was found in a number 
of  cases. Thus, in donor AL, Va21.1 was expressed in clones 
AL15.1  and  ALIII6.1,  and Va17.1  was  found in  clones 
ALIII4.3,  AL17.1, and AL4.1, although in the latter clone 
Va14.2 could also potentially pair with V/32.1. In donor BK, 
two Va2 members, Vex2.2 and Va2.6, which are 72% iden- 
tical at the amino add level, were found associated  with V132.1 
in two and, potentially three, DRw6cI-restricted clones. In 
both donors, two additional Va gene families, Va8 and Val, 
could also pair with V132.1. Altogether, at least seven  different 
Va gene segments derived from five distinct families can en- 
code a  chains able to pair with V132.1 chains to form a 
tt830-844/DK-specific binding site. Of note, however, is that 
Va21.1,  Va17.1,  Va2.2,  and VolS.1 (Vc~8.2), among the 
Va  segments  found in association with VB2.1, display a 
769  Boitd et al. Table 2.  V andJ Gene Segments Used by the u and ~ Chains of Anti-tt830-844  TCRs in Clones  frora Donors AL, BR, and KK, GAR 
Gene Segments* 
HLA-DR 
Clone T  Restriction  Vu  Jot  V/~  JB 
AL 15.3  DRw6cI  P1  Vo~21.1  JuR*  VB2.1a  J/31.2 
ALIII6.1  DRw6cI  Vu21.1  JuU*  V82. lc  JB1.1 
ALIII4.3  DRw6cI  Vu17.1  JuAF211*  V~2.1  JB2.1 
AL 17.3  DRw6cI  Vu17.1  JotF*  VB2.1c  J~2.7 
AL 4.1  DRw6cI  Pl  Vu17.1  JuAC9  VB2.1a  J~1.5 
Vu14.2s  JuAA17 
AL 8.1  DRw6cI  Pl  Vu8.1  JulGRJa06  VB2.1c  J/52.7 
AL 12.1 
AL 9.2  DRw6cI  Vul.10  JuAA17  V~2.1c  J~2.111 
ALIII3.1  DRw6cI  Vu21.1  JulGRJal0  V~21.3  JB1.5 
ALIII6.3  DRw6cI  Vu18.1  JuAL-6.3s  V~6.9  JB2.5 
Vu21.1  JuG 
AL 7.1  DRw6cI  P1  Vu17.1  JuQ*  V/319.1  JB2.7 
BR 2.2  DRw6cI  P2  ND  V~2.1c  J~1.2 
BR 7.5  DRw6cI  P3  VuS.2  JuK  VB2.1a  J~2.5 
Vu2.6  JulGRJal0 
BR 9.13  DRw6cI  P2  Vu2.6  JuR*  V~2.1c  J/$2.5 
BR 15.3  DRw6cI  Vu2.2  JuAF211  VB2.1c  J/52.7 
BR 7.3  DR4w4  Vul.2  JuAC17  V~2.1a  JB2.5 
BR 22.5  DR4w4  Vul.2  JuU  VB2.1c  JB2.4 
BR 1.7  DR4w4  Vu8.1  JuS  VB2.1c  JB2.3 
BR 3.5  DR4w4  Vu2.6  JulGRJa06*  VB8.3  J~2.5 
BR 5.11  DR4w4  Vu2.2  JaG  V~13.6s  JB2.3* 
BR 1.3  DR4w4  Vu6.1  JuH  VB7.2  J/51.3 
KT 2  DRwll.1  Vu30.1s  JulGRJa13  V~12.3  J~2.2 
GAR 9.2  DRw11.1  Vu8.2  JuS  VB19.1  JB1.2 
Vu2  JuAA13 
P Indicates promiscuous  clones which, in addition to autologous  DR recognize tt830-844 presented in the context of DRwll.2 (P1), DRw11.1, 
and DRw11.2 (P2), or DRw11.1 (P3). 
* All the following  V gene segments found in anti-tt830-844 clones have been reported by Wilson et al. (38); the original sequence designation 
is indicated  in parentheses: Votl.2 (In/4), Vot2.2 (AFl10), Vot2.6 (AA25), Vot6.1 (HAVP01), Vot8.1 (HAVP41), Vot8.2 (HAVP50), Vot17.1 (ABll), 
Vot18.1 (AB21), and Vot21.1 (AF211), V~2.1 (PL2.13), V~6.9 (L17), Vf17.2 (PL4.19), VBS.3 (VBH33) VB12.3 (PH27), V1517.1 (PH29), and Vf119 
(HBVT02). Vfl21.3 was described  in reference  (39). TheJB segments  were described  by Toyonaga  et al. (40). Jot sequences were assigned  to previously 
described Jot gene segments (37, 41, 42). 
* Clones in which a second, out-of-frame,  sequence was detected. 
S  Sequences corresponding to new V and J segments not yet described: Vot14.2, Vot30, JotAL-6.3, and VB13.6 (see Fig. 3). 
II A second in-frame V~ sequence (Vfl17.1-Jf12.6) has been found in one of nine independent sequences from this clone. 
significantly higher degree of similarity to each other (50-60% 
amino acid identity) than to members of other Vc~ families 
(<40%), with the exception of Vc~15 and Vo~23 (not shown). 
An interesting situation was noticed for the three V/$2.1- 
positive dones from BR restricted to DR4w4. Clone BR1.7 
shares the same Vc~ gene segment, Vo~8.1, as the DRw6cI- 
restricted done AL8.1. Similarly,  it was found that clones 
BR7.3 and 22.5  expressed  Votl.2, which is closely related 
to the Voll.10 segment (89% homologous at the amino acid 
level) used by the DRw6cI-restricted clone AL9.2. However, 
the TCRs of these pairs of clones differ significantly at their 
corresponding  junctional regions (Fig. 2). These observations 
suggest that germline-encoded structural components of the 
TCR may not be responsible for recognition of the DR poly- 
morphic residues, at least in this particular case, and that junc- 
tional region residues  can influence MHC specificity. 
The complexity of Vol and V~ combinations selected for 
recognition of the peptide/DR complexes studied is further 
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CDP.~  CD~ 
JLI~I~.~  V~21.I-J(XR  CAG  SYNARL MFGDGTQLVVKP NIQK  V~2.1a  -J~l.2  CSA  LPRGYYGY TFGSGTRLTVV EDL 
JLI~IXI6.1  Vu21.I-JuU  CAA  SGGOF YFGTGTSLTVIP NIQ  V~2.1c  -J~l.l  CSA  RSDPATS~ FFGQGTRLTVV EDL 
~ZIZ4.3  VUI7.I-JGtAF211  CAT  LYGONF VFGPGTRLSVLP YIQK  V~2.1  -J~2.1  CSA  RDPGGQAGFYNEO FFGPGTRLTVL EDL 
~17.3  VUI7.I-JG[F  CAA  SSGNTPL VFGKGTRLSVIA NIQN  V~2.1c -J~2.7  CSA  RASPTYEO YFGPGTRLTVT EDL 
￿9  ,I~4.~  VUI7.I-J(XAC9  CAA  ROGGSEKL VFGKGTKLTVNP  YIQN  V~2.1a -J~l.5  CSA  RGGGRE.Q  HFGDGTRLSIL EDL 
VUI4.2-JuAAI7  CAS  RTGTASKI, TFGTGTRLQVTL DIQK 
]t7~8.~  VuS.I -JUIGRJa06  CAA  ENYGGSOGNL  IFPKGTKLSVKG NIQ  V~2.1c  -J~2.7  CSA  KTGTSR~  YFGPGTRLTVT EDL 
~L~.2  VUI.10-JUAAI7  CVV  SADT~TAS~L TFGTGTRLQVTL DIQK  V~2.1c -J~2.1  CSA  RGLPGTSGVSSYN~O FFGPGTRLTVL EDL 
~XII3.1  V~21.I-J~IGRJaI0  CAA  RTYNNNDM RFGAGTRLTVKP NIQ  V~21.3  -J~l.5  CAS  SFDRVOPO HFGDGTRLSIL EDL 
￿9  ,I~7.~  V~I7.I-JuQ  CAA SSRDRGSTLGRL YFGRGTQLTVWP  DIQN  V~I9.1  -J~2.7  CAS  SITGP41 YFGPGTRLTVT EDL 
~II16.3  V~I8.I-JUALP2  CAF  SGYSTL TFGKGTMLLVSP DIQK  V~6.9  -J~2.5  CAS  TQTLAGREETO  YFGPGTRLLVL EDL 
VU21.I-JUG  CAA  RDGSGNTGKL  IFGQGTTLQVKP DIQN 
~R.~.I3  VU2.6 -JUR  CVV  NPNNARL MFGDGTQLVVKP NIQN  V~2.1c -J~2.5  CSA  LGLNOETO YFGPGTRLLVL EDL 
BR.I~.3  Vu2.2  -JUAF211  CAV  NMYDYGONF VFGPGTRLSVLP  YIQN  V~2.1c -J~2.7  CSA  RDDSGLARASGTSYEO  YFGPGTRLTVT EDL 
￿9  ~7.~  Vu2.6 -J~IGRJaI0  CW  AWKDM RFGAGTRPTVKP NIQ  V~2.1a -J~2.5  CSA  SLPGLAIEETO  YFGPGTRLLVL EDL 
VUS.2  -J(LK  CAE  NSGGSNYKL  TFGKGTLLTVNP NIQN 
~.2.2  V~2.1c  -J~l.2  CSA  RGNYGY TFGSGTRLTVV EDL 
~7.~  VUI.2  -JUACI7  CAV  SDGGAGNML TFGGGTRLMVKP  HIQN  V~2.1a  -J~2.5  CSA  SSGIEGETO YFGPGTRLLVL EDL 
~2.~  VUI.2  -JUU  CAV  SDPGAGNOF YFGTGTSLTVIP NIQN  V~2.1c -J~2.4  CSA  TSGDKNIO YFGAGTRLSVL EDL 
~.I.7  VuS.l  -JuS  CAA  EGPAGTAL  IFGKGTTLSVSS NIQ  V~2.1c -J~2.3  CSA  PRGSGLTDTO YFGPGTRLTVL EDL 
BR3.~  V~2.6 -JUIGRJa06  CW  TLPNYGngOGNL  IFGKGTKLSVKP NIQN  V~8.3  -J~2.5  CAS  GFRDLGTO YFGPGTRLLVL EDL 
~RS.lI  Vu2.2  -JUG  CAV  TIGSSNTGKL IFGQGTTLQVKP DIQN  V~13.5  -J~2.3  CAS  LADSTDTO YFGPGTRLTVL EDL 
~.3  VU6.1  -J(XH  CAM  REVSNNOGGKI, IFGQGTELSVKP NIQN  V~7.2  -J~l.3  CAS  SQDEGA~  YFGEGSWLTVV EDL 
KT~  VU30.I-JUIGRJAI3  CAG  DPGNNRKL  IWGLGTSLAVNP NIQN  V~12.3  -J~2.2  CAI  SNDLLRNTGEL FFGEGSRLTVL EDL 
G~.2  VuS.2  -JUS  CAE  MYOAGTAL  IFGKGTTLSVSS NIQN  V~19.1  -J~l.2  CAS  SIGQGMRSYGY  TFGSGTRLTVV EDL 
VU2  -JUAAI3  CAM  SAPGNEKL  TFGTGTRLTIIP NIQN 
Figure 2.  Amino  acid sequence alignment of ~ and 3 V-(D)-J regions. For each done are indicated the names of the corresponding Vg Jr,, V~, 
and J3 segments. Only the last three amino acid residues of each V segment are shown, followed  by the junctional sequences and the first three or 
four residues of the constant region. Amino acid residues are indicated using a single-letter code. The assignment of the CDR3 loop is according 
to Chothia et al. (5). J sequences contributing to each CDR3 are underlined. 
illustrated by the following examples. Gene segments Vc~21 
and Vod7 were found to be used not only in association with 
VB2.1, but with V321.3 (clone ALIID.1) and V~19.1 (done 
AL7.1), respectively. Similarly, in the TCRs of BR3.5 and 
BR5.11, Vc~2 family members found associated with V32.1 
in DRw6cI-restricted clones could pair with other V3s to 
generate,  this  time,  a DR4w4-restricted  specificity. 
Thus, despite the frequent use of V32.1 and of some Vo~ 
segments, a large number of V~V/~ combinations can con- 
stitute TCRs recognizing the tt830-844 peptide, even when 
considering dones specific for this peptide presented in the 
same HLA-DR context. Indeed, nine and five different V~V/~ 
pairs  were  found  among  13  DRw6cI-restricted  and  six 
DR4w4-restricted  clones, respectively. 
Apparent Lack of Structural Conservation in the Junctional 
Regions of anti-it830-844 TCRs.  Many different Jot and JB 
segments were found to be used by the TCRs analyzed (Table 
2). We did not notice any particular selection of Jol and J~ 
sequences that  correlated with DR restriction  or with the 
use of the same Vol and/or V~ segments. JB2.5 and JB2.7 
were found to be expressed in four and five clones, respec- 
tively, and were the most frequently usedJ~ segments. How- 
ever,  they could be associated with V/~2.1,  at well as with 
other VB segments. Jo~ use was more diverse,  with a total 
of 16 different Jc~ segments expressed in the 23 anti-tt830-844 
clones analyzed.  This may simply reflect the much greater 
size of the Jc~ versus Jfl repertoire (3), rather than sdection 
of particular Jfl segments in the anti-tt830-844 response. Al- 
though inspection of the nudeotide sequences of the Vfl-D- 
JB junctions did not always allow a dear assignment  of se- 
quences to Dill or Dfl2 segments (40), the contribution of 
D  sequences to the junctional diversity was dearly different 
from one clone to another. 
The large J repertoire and additional junctional variability 
due to imprecise joining  and N  (nudeotides)-region  addi- 
tion  was reflected in the highly  heterogeneous CDR3  se- 
quences of both Voe and Vfl regions (Fig.  2). We assigned 
the boundaries of the putative TCR CDR3 regions according 
to Chothia  et al.  (5).  The residues from J  sequences con- 
tributing to CDR3 are underlined in Fig. 2. The last posi- 
tion of the putative Va and Vfl CDR3 loops, encoded by 
the J sequence, is often a Leu and a Gln, respectively. As these 
residues are normally conserved in the respective J segments 
(37, 40-42), their role is probably to hdp maintain the overall 
conformation of the CDR3 loops, rather than to directly con- 
tact ligand (4, 5). The first position of the CDR3 equivalent 
of Vfl2.1 chains was an Arg in 7 of 14 cases.  This residue 
was germline encoded in all cases except for one, where it 
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LEADER 
M  L  L  I  T  S  M  L  V  L  W  M  Q  L  S  Q  V  N  G  Q 
ATGCTACTCATCACATCAATGTTGGTCTTATGGATGCAATTGTCACAGGTGAATGGACAA 
i0  20  30  40  50  60 
Q  V  M  Q  I  P  Q  Y  Q  H  V  Q  E  G  E  D  F  T  T  Y 
CAGGTAATGCAAATTCCTCAGTACCAGCATGTACAAGAAGGAGAGGACTTCACCACGTAC 
70  80  90  I00  ii0  120 
C  N  S  S  T  T  L  S  N  I  Q  W  Y  K  Q  R  P  G  G  H 
TGCAATTCCTCAACTACTTTAAGCAATATACAGTGGTATAAGCAAAGGCCTGGTGGACAT 
130  140  150  160  170  180 
P  V  F  L  I  Q  L  V  K  S  G  E  V  K  K  Q  K  R  L  T 
CCCGTTTTTTTGATACAGTTAGTGAAGAGTGGAGAAGTGAAGAAGCAGAAAAGACTGACA 
190  200  210  220  230  240 
F  Q  F  G  E  A  K  K  N  S  S  L  H  I  T  A  T  Q  T  T 
TTTCAGTTTGGAGAAGCAAAAAAGAACAGCTCCCTGCACATCACAGCCACCCAGACTACA 
250  260  270  280  290  300 
D  V  G  T  Y  F  C  A 
GATGTAGGAACCTACTTCTGTGCA 
310  320 
B  V(X14 .  2 
LEADER 
M  T  R  V  S  L  L  W  A  V  V  V  S  T  C  L  E  S  G  M 
ATGACACGAGTTAGCTTGCTGTGGGCAGTCGTGGTCTCCACCTGTCTTGAATCCGGCATG 
i0  20  30  40  50  60 
A  Q  T  V  T  Q  S  Q  P  E  M  S  V  Q  E  A  E  T  V  T 
GCCCAGACAGTCACTCAGTCTCAACCAGAGATGTCTGTGCAGGAGGCAGAGACTGTGACC 
70  80  90  I00  ii0  120 
L  S  C  T  Y  D  T  S  E  N  D  Y  Y  L  F  W  Y  K  Q  P 
CTGAGTTGCACATATGACACCAGTGAGAATGATTATTATTTGTTCTGGTACAAGCAGCCT 
130  140  150  160  170  180 
P  S  R  Q  M  I  L  V  I  R  Q  E  A  Y  K  Q  Q  N  A  T 
CCCAGCAGGCAGATGATTCTCGTTATTCGCCAAGAAGCTTATAAGCAACAGAATGCAACG 
190  200  210  220  230  240 
E  N  R  F  S  V  N  F  Q  K  A  A  K  S  F  S  L  K  I  S 
GAGAATCGTTTCTCTGTGAACTTCCAGAAAGCAGCCAAATCCTTCAGTCTCAAGATCTCA 
250  260  270  280  290  300 
D  S  Q  L  G  D  T  A  M  Y  F  C  A 
GACTCACAGCTGGGGGACACTGCGATGTATTTCTGTGCT 
310  320  330  340 
c  v,13.6 
S  M  T  L  Q  C  T  Q  D  M  N  H  N  Y  M  Y  W  Y  R  Q 
GAGCATGACACTGCAGTGTACCCAGGATATGAACCATAACTACATGTACTGGTATCGACA 
i0  20  30  40  50  60 
D  P  G  M  G  L  K  L  I  Y  Y  S  V  P  A  G  I  T  D  K 
AGACCCAGGCATGGGGCTGAAGCTGATTTATTATTCAGTTCCTGCTGGTATCACTGATAA 
70  80  90  i00  ii0  120 
G  E  V  P  N  G  Y  N  V  S  R  S  T  T  E  D  F  P  L  R 
AGGAGAAGTCCCGAATGGCTACAACGTCTCCAGATCAACCACAGAGGATTTCCCGCTCAG 
130  140  150  160  170  180 
L  E  L  A  A  P  S  Q  T  C  L  Y  F  C  A  S 
GCTGGAGTTGGCTGCTCCCTCCCAGACATGTCTCTACTTCTGTGCCAGC 
250  260  270  280  290 
D  J(X-AL6.3 
F  S  G  Y  S  T  L  T  F  G  K  G  T  M  L  L  V  S  P 
TTTTCAGGATACAGCACCCTCACCTTTGGGAAGGGGACTATGCTTCTAGTCTCTCCA 
i0  20  30  40  50  60 
Figure 3.  Nudeotide sequences and corresponding 
amino acid translation of new human variable and 
joining segments.  (A) A proposed new V~ family, 
Vot30, expressed in clone KT2. When compared to 
all known human Vot sequences,  Va30  shows  the 
highest degree of nucleotide sequence identity (69%) 
with one member of the V~10 family (38). (B) Vod4.2 
(from  clone AL4.1)  and  (C)  VB13.6  (from  clone 
BR5.11)  correspond to new sequences belonging to 
already  described  families.  Vod4.2  shares  93.5% 
nucleotide identity with the HAVT20 prototype (38) 
of the Vod4 family. VB13.6 is a partial sequence but 
shows 90-96% nudeotide identity with the previously 
described sequences of the V/313 family HBP34 (38), 
CEM (38), 17A2 and G36 (44). The presumed leader 
sequence of Va30 and V~14.2 is overlined. These new 
sequences have been submitted to the GenBank nudeo- 
tide data base and have been assigned  the accession 
numbers: M64350  (Vot30),  M64354  (VB14.2),  and 
M64355 (V/313.6). (D) A new J~ segment, designated 
J~AL-6.3, according to the name of the corresponding 
clone (ALIII6.3). 
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DRwlI.2  ..................................................................  I---E  ..............  V ........ 
DRw6cI  ...............................  H ....  N ....................  A ........  I---E  ..............  V ........ 
DR4w4  .........  QV-H  ...................  H .............  Y ..........  A ........  L--QK  ....................... 
Figure 4.  Amino acid sequence 
of the first domain of the 13 chain 
of DKw11.1, DKwll.2, DRw6cI, 
and DK4w4  alleles. Amino acid 
residues are indicated using single- 
letter code and are from reference 
59; (dashes) identity to the DKw11.1 
sequence. Below the sequence is a 
schematic representation of the pro- 
posed secondary structure of DRB 
chain; (black boxes) [3 strands, (grey 
box) the ~x-helix, and (thin  lines) 
turns and bends of the polypeptide 
chain. 
arose from somatic diversification mechanisms (not shown). 
In the V~2.1  chain of clone AL8.1, a conservative Lys for 
Arg substitution has taken place. However, it is evident that 
the putative V~ CDK3s of the anti-tt8300844  TCKs ana- 
lyzed show dramatic differences  in both length (6-16 residues) 
and/or amino acid composition. This is observed even for 
the  junctional regions of TCRs that use members of the same 
Vc~ family and the same V~ and that are restricted to the 
same DR., such as clones ALIII4.3,  AL17.3, and AL4.1, or 
BK15.3, BK9.D, and BK7.5  (for AL 4.1 and BR7.5, it is 
tentatively assumed that Vc~17.1 and Vot2.6, respectively,  each 
pair with V~2.1), or clones AL15.3 and ALIII6.1. The only 
exception to this striking lack of  junctional sequence conser- 
vation is represented by clones BK7.3  and BK22.5,  which 
are both restricted to DR4w4, where the use of the same 
Vc~ and VB gene segments is accompanied by relatively con- 
served Vo~ CDR3s, both in amino acid composition and in 
length. Their V~/CDK3s, however, differ markedly. 
In summary, among the 23 independent clones analyzed, 
22 unique VlgD-J~ and 25 unique Vc~-Jc~  junctions were 
found and, with a single exception, no greater junctional se- 
quence conservation was observed among TCKs with iden- 
tical Vo~ and/or V~ gene segments than among those with 
different ones. 
Discussion 
Previous studies in the mouse system (10018) have  demon- 
strated that, with a notable exception (45), TCRs selected 
in response to a defined peptide-Ia complex use a restricted 
number of Vo~/VB gene segment combinations.  In the one 
exception,  involving  the response  to  a determinant from 
influenza virus hemaglutinin, a markedly more diverse TCR 
repertoire  was found. In all these studies, however, TCKs 
that used the same V region germline gene segments gener- 
ally expressed closely related (or identical)junctional region 
amino acid sequences, suggesting  that V regions and junc- 
tional sequences are functionally coselected. Thus,  in the 
cytochrome c system (15), among nine murine clones ex- 
pressing V~3, all were found to have the same number of 
amino acids spanning the V~/-D-J/3  junction, and eight had 
an asparagine at position 100. Indeed, site-directed mutagen- 
esis of this residue was shown to affect recognition (46). 
To investigate whether a similar structural conservation 
of TCRs specific  for a defined antigen/MHC complex is found 
in antigen-primed human donors and, at the same time, to 
obtain further insights into the molecular mechanism of an- 
tigen and MHC recognition, we analyzed the TCKs selected 
in a DR-restricted memory T cell response to the tt epitope 
tt8300844. Since  tt8300844 can be recognized in association 
with most DR molecules (20), this system also offered an 
opportunity to evaluate  the influence of  changing the antigen- 
presenting molecule on the selection of TCR variable region 
components. In addition, the tt830-844 peptide seems to bind 
to different DR molecules in a similar orientation (20~ 
This should simplify interpretation of the observed response. 
Our analysis of a large panel of anti-tt8300844  human T cell 
clones has revealed repeated use of a particular  V~ region 
gene segment, as often observed in the mouse system. In con- 
trast to previous studies, however, no apparent conservation 
in the length and/or amino acid composition of Vol or VB 
junctional regions could be detected, even  among TCKs with 
identical Vo~ and/or VB gene segments. 
A particular V~/gene product, VB2.1, was preferentially 
used by anti-tt8300844-specific TCKs, irrespective  of  whether 
the peptide was presented by DK6wcI, DR4w4, or DRw11.1 
and DRw11.2  alleles in three of the donors studied.  Thus, 
shared MHC class II antigens are not required for shared V~ 
gene usage by TCRs specific for this peptide. This result is 
consistent  with the finding by Wucherpfenning et al. (47) 
that TCKs reactive with an MBP-derived peptide and ex- 
pressing V~12 or VB17 can be isolated from DR2-, DR3-, 
or DR4-positive patients. As in the present study, preferen- 
tial use of a particular  V~ gene segment (VB17) in T cell 
clones specific for this peptide was also found. Another re- 
cently described case of restricted TCK gene expression in 
humans is that of Vod7 use by tumor-infiltrating lympho- 
cytes in uveal melanoma (48). In this case, however, the na- 
ture of the targeted antigen(s)  is  unknown. In the anti- 
tt830-844 response, no preferential  use of other Vfls was found 
in a series of clones not expressing V~2.1,  suggesting that 
the latter is strongly selected, at least in the individuals studied, 
for interacting with a structural determinant common to the 
different peptide/DR complexes  recognized. These complexes 
share an identical DR o~ chain, but the corresponding DR 
chain display 3-11 amino acid substitutions  when com- 
773  Boitel et al. pared with one another (Fig. 4). According to the proposed 
structural model of class II MHC (23), some of these poly- 
morphic residues (on the floor of, or pointing inside the MHC 
pocket) may influence the way in which the peptide binds 
to the restricting element, and others (on the top of the DRB 
c~ helix) may interact with the TCR and are unlikely to 
influence the determinant seen  by V~2.1. Moreover, tt830-844 
has been shown to interact with different DR alleles via 
common residues (21). It is therefore likely that the promis- 
cuous binding of this peptide is the result of the interaction 
between these residues and sites conserved in different DR 
molecules (20, 21). Given this apparently similar orientation 
of the peptide in the DR molecules, one would expect that 
different complexes share, at least in part, a common T cell 
determinant that can be seen by VB2.1. This hypothesis is 
favored by the observation that, with one exception, all clones 
displaying promiscuous recognition use V~2.1 (see Table 2). 
However,  further studies will be needed to clarify whether 
the determinant selecting V~/2.1 is borne by the nonpoly- 
morphic c~ chain of DR or by a common motif of the DR 
chain, or rather of the peptide, or of both the peptide and 
DR molecule. 
The Vc~ use in the 21 clones analyzed was not biased to 
only one Vc~ chain, as observed for VB. For instance, if we 
consider the 10 clones using V~2.1 and restricted to DRw6cI, 
a minimum of six (to a maximum of eight) different Vot 
family members could be used to recognize this complex. 
It is worth noting, however, that Vot2.2., VotS.1 (Vc~8.2), 
Vc~17.1, and Vot21.1, which are among the Vo~ gene seg- 
ments most frequently associated  with  V~2.1,  display  a 
significantly higher degree of similarity to each other (50-60% 
amino acid identity) than to most Vc~ members (<40% iden- 
tity). Thus, one may speculate that they all share a minimal 
structural element important in forming a similar antigenic 
specificity and/or restriction. This possibility is consistent 
with what is known from sequencing and x-ray crystallo- 
graphic  analysis of  anti-phosphorylcboline (49)  and  an- 
tiphenyloxazolone (50)  antibodies about how a particular 
binding specificity may be preserved, even after substitution 
of a given H  (or L) chain by another, apparently unrelated 
one. In the former case, the H chains are invariably derived 
from the same V. germline gene, and the L chain sequences 
may belong to any of three different subgroups (49). In the 
latter case, a given H chain may be functionally replaced by 
a variety of other, seemingly unrelated ones, provided the 
L chain is retained (50). In both cases, however, key antigen- 
contacting residues are found to be conserved in the substituted 
chain. Another possible explanation for the diversity of c~ 
chains which may be paired with VB2.1-encoded B chains 
is that recognition is mostly mediated by the ~  chain and 
that the ot chain plays only a secondary role and so is not 
functionally selected. In this context, Tan et al. (51) have shown 
that transfer of the ot chain alone of an arsonate-specific TCR 
into a recipient T cell with an unrelated B chain is suf~cient 
to confer responsiveness to the hapten, implying that one 
chain of the TCR may be functionally dominant over the 
other in certain  cases. 
It is interesting that clones expressing the same or very 
closely related Vc~ and the same VB segments, but displaying 
distinct junctional amino acid sequences,  could recognize 
tt830-844 in the context of two different DR alleles. It there- 
fore appears that in some cases TCRjunctional regions may 
dictate the restriction by recognizing either a DR allele-de- 
pendent conformation of the peptide or polymorphic residues 
of the DR ~  chain. A situation in which TCR junctional 
regions seem critical to recognition of both antigen and MHC 
has been described by Rupp et al. (52) who found that an 
alloreactive,  H-2Db-specific,  cytotoxic T  cell clone and  a 
chicken erythrocyte-specific,  I-Ab-restricted,  helper  done 
share identical Vot and V~ gene segments, but differ in their 
junctional sequences. Thus, alterations in the putative CDR3 
regions of the TCR may affect peptide specificity but not 
MHC restriction (15-18), both antigen recognition and MHC 
restriction (52),  or only MHC specificity but not peptide 
reactivity,  as in the present work. 
The most striking finding of this study was the remark- 
able diversity in the  junctional regions of the 23 anti-tt830-844 
T  cell clones analyzed,  even when comparing TCRs com- 
posed of identical Vc~ and/or VB gene segments. Thus, among 
14 anti-tt830-844 T cell clones using the VB2.1 gene seg- 
ment, 14 unique VB-D-JB junctions were found, with no 
evident conservation of length and/or amino acid composi- 
tion, and with only a single positively charged amino acid 
residue conserved at the NH~-terminal position of the puta- 
tive CDR3s of eight of them (Table 2). However,  the fact 
that this residue is not always conserved, as well as being 
encoded by the germline VB2.1 gene segment (9) in seven 
of the eight cases, argues against any particular selection of 
this residue for recognition. Lack of structural conservation 
was also found for most of the putative CDR3s of the c~ 
chains, whether or not they were associated with the same 
Vot gene segment or were part of TCRs using the same V/3 
gene segment. One exception was represented by clones BR7.3 
and BR22.5, whose ot chain CDR3 junctions are partially 
conserved in length and amino acid composition. Here too, 
however, one finds the substitution of a Gln by a Pro, which 
may significantly affect the conformation of the CDR3 loop 
(53). Moreover, the Vfl CDR3s of these clones differ markedly. 
Recently, two studies in the mouse investigating class I-re- 
stricted responses to a lymphocytic choriomeningitis virus 
(LCMV) undecapeptide in a transgenic system (54), and to 
a Plasmodium  berghei nonapeptide (55), found substantially 
different  V~-D-JB junctional regions in  the context of a 
common Vfl. Thus, together with ours, these results indi- 
cate that variability in the  junctional regions of TCRs specific 
for an identical peptide/MHC complex is not exceptional and 
may depend on the particular peptide (or epitope) recognized. 
One interpretation for the apparent lack of selection  of 
specific  junctional sequences in the context of a common V 
(Vfl and/or Vc  0 region element is that the  junctional regions 
of these TCRs do not play a major role in recognition of 
the tt830-844/DR complex and so are not structurally con- 
strained. That the putative CDR.3 regions have at least some 
influence on recognition, however, is shown by the effect of 
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In addition, changes in the junctional sequences may alter 
the affinity or fine specificity of these TCRs. Nevertheless, 
the strong selection for V~2.1, but not for any particular 
junctional sequence(s), found in many anti-tt830-844 clones 
suggests that the former may be responsible for most of the 
key contacts with the peptide/MHC complex. It is instruc- 
tive to examine this situation in the light of what is known 
about the selection of particular CDR. sequences in antibodies. 
In this case, x-ray crystallographic analysis has shown that 
the strict maintenance of certain amino acid sequences, such 
as those at the potentially highly variable VL-JL  and V,-D-J, 
junctions (CDR3s) observed among anti-phosphorylcholine 
(49) and anti-phenyloxazolone (50) antibodies, is largely due 
to structural constraints related to antigen recognition. Con- 
versely, CDRs that make no contacts with antigen, such as 
V, CDR2 of anti-phenyloxazolone antibodies (50), are not 
functionally restrained and may show extensive sequence vari- 
ability.  An interesting finding in this respect is that an L d- 
reactive cytolytic T cell clone using the same Vc~ segment 
(Vcr  as an I-Aa-restricted arsonate reactive one, but an un- 
related V~-Jc~ junction and/3 chain, also responds to this 
hapten, suggesting that CDR3 sequences may not be crit- 
ical to arsonate  recognition (51). 
Alternatively, our data can be interpreted in terms of re- 
cently proposed models for TCR recognition of peptide/MHC 
complexes in which CDR1 and CDR2 of the V regions in- 
teract with MHC determinants, and the CDR3 junctional 
regions bind to the antigenic peptide (3, 5, 56). Assuming 
that  all  V~2.1-containing  TCRs  bind  to  the  same 
tt830-844/DR complex in the same general orientation as 
the result of conserved contacts between the first two CDRs 
of this domain and the DR molecule, one is confronted with 
the obvious difficulty of physically accommodating  such highly 
heterogeneous CDR3s in what is predicted to be the geo- 
metrical center of the interface between the TCR and the 
peptide/MHC complex (3, 5, 56). This problem is even more 
difficult for TCRs using the same Voe and V3 segments. One 
possibility is that the V32.1 CDR3s and Vot CDR3s differing 
dramatically in primary structure, may actually fold into similar 
three-dimensional conformations. This, however, appears un- 
likely based on the similarity between Ig and TCR frame- 
works (5) and on detailed studies of the conformations of 
VL and V. CDR3s in antibodies of known three-dimen- 
sional structure (53).  An alternative hypothesis to explain 
CDR3 heterogeneity in TCRs recognizing the same com- 
plex is that certain peptides bound to the MHC pocket possess 
a degree of freedom allowing some of the peptide side chains 
to assume different conformations (17). This in turn may re- 
sult in different complexes selecting the same V regions (which 
contact the MHC molecule), but very different junctions. 
It is also possible that even TCRs using the same V~ (and 
VoQ germline gene segments may have different views of the 
same pepdde/DR complex or see different parts of tt830-844, 
thus explaining the  junctional variability observed. However, 
preliminary studies examining the effects of multiple substi- 
tutions at every position of tt830-844 on recognition by some 
of the VB2.1-expressing  clones reported here indicate that 
the segment seen by these clones does not include the NH2- 
terminal  (Q)  and  the  last  four  COOH-terminal  (ITEL) 
residues of tt830-844. Furthermore, these clones are all affected 
by substitutions in the central region of the tt830-844, indi- 
cating that they interact with the same stretch of the peptide. 
Finally, it is conceivable that in our particular case the pep- 
tide/MHC complex may be heavily tilted toward the VB do- 
main and yet maintain the same overall alignment relative 
to the latter, as in the proposed models (4, 5, 56). This would 
have the effect of partially disengaging V~ CDR3 (as well 
as the entire Vo~ domain) from the interface between the TCtL 
and the peptide-MHC complex, and potentially allowing for 
greater sequence variability  at the V/~-D-J~ junction. It is 
interesting that cases of asymmetrical positioning of the an- 
tibody heterodimer on the surface of antigen, resulting in 
markedly unequal contributions of VL versus V. domains to 
formation of the interface  with  antigen,  have been well 
documented in  x-ray  crystallographic studies of antigen- 
antibody complexes (57,  58). 
Further experiments involving the use of analogues  of 
tt830-844 carrying a large number of substitutions, as well 
as TCR reconstitutions by transfection employing different 
combinations of ot and/3 chains, should help to distinguish 
among these possibilities. 
To our knowledge, the present study represents the most 
extensive analysis to date illustrating the complexity of TCR 
structural components repertoire selected for a well-defined 
epitope in the human. In addition, this system represents  a 
useful model for further understanding the rules governing 
T  cell recognition. 
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